Fatal spontaneous retroperitoneal hematoma secondary to enoxaparin

Southern Medical Journal

Volumn 96, Issue 1, 2003, Pages 58-60

  Chan Tack, Kirk M ^a,b  

^a University of Missouri   (United States)

^b EVANSTON HOSPITAL   (United States)

Author keywords

Acute coronary syndromes; Enoxaparin; Hematoma

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; ENOXAPARIN; FUROSEMIDE; GLYCERYL TRINITRATE; PARACETAMOL; SULTAMICILLIN;

ABDOMINAL DISTENSION; ACUTE DISEASE; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; CAUSE OF DEATH; DISEASE COURSE; DIURESIS; DRUG FATALITY; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LABORATORY TEST; LUNG EDEMA; PAIN; PATIENT CARE; PNEUMONIA; RETROPERITONEAL HEMATOMA; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; ENOXAPARIN; FATAL OUTCOME; FEMALE; HEMATOMA; HUMANS; RETROPERITONEAL SPACE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037274777     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000047721.97440.02     Document Type: Article

References (10)

1. Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease: Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997;337:447-452.
2. Gurfinkel EP, Manos EJ, Mejail RI, et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol 1995;26:313-318.
3. Thrombolysis in Myocardial Infarction (TIMI) IIA Trial Investigators. Dose-ranging trial of enoxaparin for unstable angina: results of TIMI IIA: The Thrombolysis in Myocardial Infarction (TIMI) IIA Trial Investigators. J Am Coll Cardiol 1997;29:1474-1482.
4. Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) IIB trial. Circulation 1999;100:1593-1601.
5. Antman EM, Cohen M, Radley D, et al. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction: TIMI IIB-ESSENCE meta-analysis. Circulation 1999;100:1602-1608.
6. Noble S, Spencer CM. Enoxaparin: A review of its clinical potential in the management of coronary artery disease. Drugs 1998;56:259-272.
7. Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992;79:1-17.
8. Frydman A. Low-molecular-weight heparins: An overview of their pharmacodynamics, pharmacokinetics and metabolism in humans. Haemostasis 1996;26(Suppl 2):24-38.
9. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997;337:688-698.
10. Montoya JP, Pokala N, Melde SL. Retroperitoneal hematoma and enoxaparin. Ann Intern Med 1999;131:796-797 (letter).